← Back to headlines
Kodiak Stock Rises on Positive Diabetic Retinopathy Trial Results
Kodiak Sciences saw its stock climb after announcing positive results from a late-stage clinical trial for its diabetic retinopathy therapy.
26 Mar, 11:04 — 26 Mar, 11:04
Sources
Showing 1 of 1 sources
Related Stories
Education Secretary Angara Promotes Farm-to-School Links in Batangas
just now
Philippine 911 Center Records Over 3,300 VAWC Calls in Early 2025-2026
just now
Philippine President Marcos Jr. Inspects Agri Facilities in Isabela
just now
PNP to Strengthen Community Ties to Combat Rising Suicide Cases
just now